3C-P: Difference between revisions
>ChristopherFye Added information about legal status of 3C-P in Japan. |
>David Hedlund {{Experience reports|erowid_experience_substance_label=3C-P}} |
||
(8 intermediate revisions by 6 users not shown) | |||
Line 4: | Line 4: | ||
{{approval}} | {{approval}} | ||
'''3,5-Dimethoxy-4-propoxyamphetamine''' ( | '''3,5-Dimethoxy-4-propoxyamphetamine''' (also known as '''3C-P''' or '''3C-Proscaline''') is a lesser-known [[psychoactive class::psychedelic]] substance of the [[chemical class::Substituted amphetamines|amphetamine]] class. Although its name suggests it may be related to the [[2C-x]] family, this is not the case since it is the 3-Carbon analog of [[proscaline]]. | ||
The original synthesis date of 3C-P is unknown. Its theoretical synthesis is briefly mentioned in [[Alexander Shulgin|Alexander Shulgin's]] book [[PiHKAL]], in which it is speculated to have psychedelic properties and a presumed dosage range of 20 to 40 milligrams.<ref>https://erowid.org/library/books_online/pihkal/pihkal140.shtml</ref> It is typically sold on the online [[research chemical]] market. | |||
Very little data exists about the pharmacological properties, metabolism, and toxicity of 3C-P, and it has only a brief history of human usage. It is highly advised to use [[harm reduction practices]] if using this substance. | |||
==Chemistry== | ==Chemistry== | ||
Line 27: | Line 27: | ||
==Subjective effects== | ==Subjective effects== | ||
{{Preamble/SubjectiveEffects}} | {{Preamble/SubjectiveEffects}} | ||
{{effects/base | {{effects/base | ||
|{{effects/physical| | |{{effects/physical| | ||
*'''[[Effect::Stimulation]]''' - In terms of its effects on the physical energy levels of the user, 3C- | *'''[[Effect::Stimulation]]''' - In terms of its effects on the physical energy levels of the user, 3C-P is usually considered to be moderately to extremely stimulating. In comparison, other more commonly used psychedelics such as [[psilocin]] are sedating and relaxed. | ||
*'''[[Effect::Spontaneous physical sensations]]''' | *'''[[Effect::Spontaneous physical sensations]]''' | ||
**'''[[Effect::Physical euphoria]]''' | **'''[[Effect::Physical euphoria]]''' | ||
Line 133: | Line 134: | ||
}} | }} | ||
===Experience reports=== | ===Experience reports=== | ||
{{Experience reports|erowid_experience_substance_label=3C-P}} | |||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
Line 146: | Line 145: | ||
It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this substance. | It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this substance. | ||
=== | ===Dependence and abuse potential=== | ||
3C-P is [[Addiction potential::not habit-forming]], and the desire to use it can actually decrease with use. It is most often self-regulating. | 3C-P is [[Addiction potential::not habit-forming]], and the desire to use it can actually decrease with use. It is most often self-regulating. | ||
Line 160: | Line 159: | ||
*'''United Kingdom''': It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted</ref> | *'''United Kingdom''': It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted</ref> | ||
*'''United States''': 3C-P is technically not scheduled in the United States, but could be considered an analog of [[mescaline]] and may, therefore, be considered a Schedule I drug under the Federal Analogue Act. | *'''United States''': 3C-P is technically not scheduled in the United States, but could be considered an analog of [[mescaline]] and may, therefore, be considered a Schedule I drug under the Federal Analogue Act. | ||
*'''Japan''': 3C-P is a controlled substance in Japan effective February 28th, 2018. | *'''Japan''': 3C-P is a controlled substance in Japan effective February 28th, 2018.<ref>[https://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/iyakuhin/yakubuturanyou/oshirase/20180228-1.html 指定薬物を指定する省令が公布されました] (in Japanese). 厚生労働省 [Ministry of Health, Labour and Welfare (MHLW)]. Retrieved May 2, 2022.</ref> | ||
==See also== | ==See also== |